CMS proposes to Withdraw Trump Era Most Favored Nation (MFN) Drug Pricing Rule
FDA Law Blog
AUGUST 10, 2021
The idea of basing Medicare drug reimbursement on prices in foreign countries was first proposed during the Obama Administration in 2016. Use of international reference pricing as a target for Medicare to negotiate prices with drug manufacturers appears in H.R. The Trump Administration rule had a troubled history. 3 , the “Elijah E.
52 
Let's personalize your content